228 related articles for article (PubMed ID: 31240523)
1. A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials.
Shaikh SS; Kumthekar PU; Mohindra NA
J Neurooncol; 2019 Aug; 144(1):235-237. PubMed ID: 31240523
[No Abstract] [Full Text] [Related]
2. Preventing central nervous system metastases in non-small cell lung cancer.
Krawczyk P; Duchnowska R; Nicoś M; Kowalski D; Wojas-Krawczyk K
Expert Rev Anticancer Ther; 2018 Nov; 18(11):1077-1083. PubMed ID: 30198357
[TBL] [Abstract][Full Text] [Related]
3. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
Santana-Davila R; Chow LQ
Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
[No Abstract] [Full Text] [Related]
4. [Immunotherapy for non-small cell lung cancer--novel approaches to improve patient outcome].
Shepherd FA; Douillard JY; Blumenschein GR
Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):C9-20. PubMed ID: 23601304
[TBL] [Abstract][Full Text] [Related]
5. Vaccines and immunotherapy for non-small cell lung cancer.
Morgensztern D; Goodgame B; Govindan R
J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S463-5. PubMed ID: 21102240
[No Abstract] [Full Text] [Related]
6. Current clinical immunotherapy targets in advanced nonsmall cell lung cancer (NSCLC).
McCarthy F; Roshani R; Steele J; Hagemann T
J Leukoc Biol; 2013 Dec; 94(6):1201-6. PubMed ID: 23695306
[TBL] [Abstract][Full Text] [Related]
7. [Management of non-small cell lung cancer patients harboring activating mutations and CNS progression].
Rouviere D; Veillon R; Chaltiel L; Simonneau Y; Filleron T; Milia J; Guibert N; Melloni B; Raherison C; Didier A; Mazieres J
Rev Mal Respir; 2019 May; 36(5):583-590. PubMed ID: 31202602
[TBL] [Abstract][Full Text] [Related]
8. Selecting patients for immune checkpoint inhibition in lung cancer.
Garon EB
Clin Adv Hematol Oncol; 2015 Aug; 13(8):490-2. PubMed ID: 26351808
[No Abstract] [Full Text] [Related]
9. To Treat or Not to Treat: Role of Immunotherapy in Patients with Concomitant Diagnosis of Advanced-Stage Non-Small Cell Lung Cancer and Psoriasis.
Khunger M; Calabrese C; Kontzias A; Velcheti V
J Thorac Oncol; 2017 Sep; 12(9):e147-e149. PubMed ID: 28838717
[No Abstract] [Full Text] [Related]
10. Biomarkers for Immunotherapy.
Bustamante-Alvarez JG; Owen DH
Thorac Surg Clin; 2020 May; 30(2):207-214. PubMed ID: 32327179
[TBL] [Abstract][Full Text] [Related]
11. Recent clinical trials of immunotherapy in non-small-cell lung cancer.
Gkolfinopoulos S; Mountzios G
Immunotherapy; 2019 Apr; 11(6):461-466. PubMed ID: 30860438
[No Abstract] [Full Text] [Related]
12. Advances in immunotherapy for non-small cell lung cancer.
Reckamp KL
Clin Adv Hematol Oncol; 2015 Dec; 13(12):847-53. PubMed ID: 27058851
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in the treatment of non-small cell lung cancer.
Bílek O; Bořilová S; Grell P; Kiss I
Klin Onkol; 2021; 34(Supplementum 1):54-64. PubMed ID: 34154331
[TBL] [Abstract][Full Text] [Related]
14. Immune modulation as a therapeutic strategy for non-small-cell lung cancer.
Holt GE; Disis ML
Clin Lung Cancer; 2008 Feb; 9 Suppl 1():S13-9. PubMed ID: 18540530
[TBL] [Abstract][Full Text] [Related]
15. [Non-small cell lung cancer: news from immunotherapy].
Reinmuth N; Heigener DF; Reck M
Dtsch Med Wochenschr; 2015 Mar; 140(5):329-33. PubMed ID: 25734674
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy.
Zheng H; Zeltsman M; Zauderer MG; Eguchi T; Vaghjiani RG; Adusumilli PS
Immunotherapy; 2017 Sep; 9(11):913-927. PubMed ID: 29338609
[TBL] [Abstract][Full Text] [Related]
17. [Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer].
Wang S; Li J
Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):682-686. PubMed ID: 27760599
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?
Rolfo C; Sortino G; Smits E; Passiglia F; Bronte G; Castiglia M; Russo A; Santos ES; Janssens A; Pauwels P; Raez L
Expert Rev Anticancer Ther; 2014 Oct; 14(10):1173-87. PubMed ID: 25148289
[TBL] [Abstract][Full Text] [Related]
19. [The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].
Wang ZM; Song Y
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):95-99. PubMed ID: 32062879
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic cranial irradiation with combined modality therapy for patients with locally advanced non-small cell lung cancer.
Cho LC; Dowell JE; Garwood D; Spangler A; Choy H
Semin Oncol; 2005 Jun; 32(3):293-8. PubMed ID: 15988684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
